Onkure Therapeutics Inc (OKUR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 110,761 | 29,876 | 19,927 | 124,660 | 53,613 |
| Marketable Securities | N/A | N/A | 81,246 | 23,010 | 0 |
| TOTAL | $113,003 | $33,766 | $106,353 | $153,734 | $55,025 |
| Non-Current Assets | |||||
| PPE Net | 1,025 | 1,432 | 453 | 212 | 69 |
| Other Non-Current Assets | 879 | 536 | 1,376 | 78 | 127 |
| TOTAL | $1,904 | $1,968 | $1,829 | $290 | $196 |
| Total Assets | $114,907 | $35,734 | $108,182 | $154,024 | $55,221 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,968 | 3,417 | 1,893 | 2,022 | 908 |
| Accrued Expenses | 7,026 | 3,660 | 4,827 | 4,180 | 3,672 |
| TOTAL | $10,530 | $7,285 | $7,124 | $6,202 | $4,580 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 549 | 466 | 1,088 | 611 | 0 |
| TOTAL | $549 | $466 | $1,088 | $611 | $36 |
| Total Liabilities | $11,079 | $7,751 | $8,212 | $6,813 | $4,616 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 13,436 | 3,342 | 2,511 | 2,446 | N/A |
| Common Shares | 1 | N/A | 3 | 3 | N/A |
| Retained earnings | -154,724 | -102,051 | -136,683 | -84,728 | -44,958 |
| Other shareholders' equity | 0 | 129,825 | -43 | 34 | 92,720 |
| TOTAL | $103,828 | $27,983 | $99,970 | $147,211 | $50,605 |
| Total Liabilities And Equity | $114,907 | $35,734 | $108,182 | $154,024 | $55,221 |